Category Archives: Uncategorized

Judge rejects GM’s request for broad protective order in litigation over defective ignition switches

The judge rejected a motion for a broad protective order but issued a narrower one. Reuters reports: A federal judge overseeing litigation over multiple General Motors recalls last year will allow plaintiffs' lawyers to share some nonconfidential material gathered during discovery, rejecting the company's bid to broadly ban public pretrial dissemination of the material. On […]

Marketplace morning report on NPR: Chipotle facing wage/hour lawsuits

After discussing various cases against Chipotle based on misclassification and off-the-clock work, the story goes on to claim that private wage/hour enforcement is rising in general. The reaction of the industry representative interviewed for the story is telling: “Plaintiffs’ attorneys, the employees’ attorneys, became aware that this was sort of lucrative ground for them to […]

More on the Fiat Chrysler recalls – control problems and explosions

Brian posted earlier this morning about cyber-security concerns leading to some of the recalls. Two other notable aspects of today's recall and $105 million fine, the largest in U.S. history, are: -The company will offer to buy back up to half a million Dodge Ram pickups because of suspension problems that can result in a […]

Will California’s new kid vaccination law become a model for the country?

Laws in all states generally require kids to be vaccinated against various childhood diseases before they may attend school. (And, of course, school attendance itself is legally required.) But most of those laws have exceptions to accommodate parents' religious and philosophical objections. (And the laws don't require kids to be vaccinated when their medical conditions […]

Third Circuit joins circuit consensus on Comcast, also reaffirms that standing need not be established for each class member

Yesterday, in a product-defect class action about Volvos with faulty sunroofs, the Third Circuit addressed two important class action questions — one arising in the wake of the Supreme Court's decision in Comcast Corp. v. Behrend, the other to be examined in the upcoming term in Tyson Foods v. Bouaphakeo. The Comcast question, which we've […]

FDA to study effect of drug-ad boasting on patient perceptions

The Wall Street Journal explains: Time and again, consumer ads claim a medicine is the number one drug prescribed by physicians. Putting aside the question of whether such boasting is actually true, what remains unclear is the extent to which consumers view such information positively or as a substitute for effectiveness data. And so, the […]